Zobrazeno 1 - 10 of 59 pro vyhledávání: '"Chantal M Wiepjes"'
1
Akademický článek
The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis.
Autor: Moya H Schutte, Robert Kleemann, Nienke M Nota, Chantal M Wiepjes, Jessica M Snabel, Guy T'Sjoen, Abel Thijs, Martin den Heijer
Publikováno v: PLoS ONE, Vol 17, Iss 3, p e0261312 (2022)
BackgroundCardiovascular risk is increased in transgender persons using gender-affirming hormone therapy. To gain insight into the mechanism by which sex hormones affect cardiovascular risk in transgender persons, we investigated the effect of hormon
Externí odkaz: https://doaj.org/article/969b45d14b0f45f1a5e72909bb3e4677
Zobrazit plný text záznamu
2
Akademický článek
Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study
Autor: Christel JM. de Blok, Benthe AM. Dijkman, Chantal M. Wiepjes, Inge RHM. Konings, Koen MA. Dreijerink, Ellis Barbé, Martin den Heijer
Publikováno v: Breast, Vol 57, Iss , Pp 118-122 (2021)
No literature is available on the benign versus malignant breast lesion ratio in trans women (male sex assigned at birth, female gender identity). As hormone treatment in trans women results in breast tissue histologically comparable with cis (non-tr
Externí odkaz: https://doaj.org/article/1d10da61632a4e7db9d43dc5f64f8899
Zobrazit plný text záznamu
3
Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment
Autor: Amirun Rahmat, Iris De Nie, Chantal M. Wiepjes, Martin Den Heijer, Thomas Rustemeyer, Christel J. M. De Blok, Koen M. A. Dreijerink
Publikováno v: Rahmat, A, De Nie, I, Wiepjes, C M, Den Heijer, M, Rustemeyer, T, De Blok, C J M & Dreijerink, K M A 2023, ' Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment : a nationwide cohort study in the Netherlands ', International Journal of Dermatology, vol. 62, no. 7, pp. 882-887 . https://doi.org/10.1111/ijd.16707
International Journal of Dermatology. Wiley-Blackwell
BACKGROUND: Development of skin cancer, in particular melanoma, has been linked to sex hormones. We aimed to determine the incidence of skin cancer in transgender individuals receiving gender-affirming hormone treatment (GAHT).METHODS: In this nation
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03590aeafa452c141b31f234f171b54d
http://www.scopus.com/inward/record.url?scp=85158026345&partnerID=8YFLogxK
Zobrazit plný text záznamu
4
Changes in laboratory results in transgender individuals on hormone therapy: a retrospective study and practical approach
Autor: Evelien T M Boekhout-Berends, Chantal M Wiepjes, Nienke M Nota, Hans H M Schotman, Annemieke C Heijboer, Martin den Heijer
Publikováno v: European Journal of Endocrinology. 188:457-466
Objective Interpreting laboratory results for transgender individuals who started hormone therapy requires careful consideration, specifically for analytes that have sex-specific reference intervals. In literature, conflicting data exist on the effec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::afb8601d24540ea6e2ad7c5da9a389a4
https://doi.org/10.1093/ejendo/lvad052
Zobrazit plný text záznamu
5
Sex hormones, insomnia, and sleep quality:Subjective sleep in the first year of hormone use in transgender persons
Autor: Margot W.L. Morssinkhof, Chantal M. Wiepjes, Breanna W. Bosman, Jim Kinds, Alessandra D. Fisher, Yona Greenman, Baudewijntje P.C. Kreukels, Guy T'Sjoen, Ysbrand D. van der Werf, Martin den Heijer, Birit F.P. Broekman
Publikováno v: Morssinkhof, M W L, Wiepjes, C M, Bosman, B W, Kinds, J, Fisher, A D, Greenman, Y, Kreukels, B P C, t'Sjoen, G, van der Werf, Y D, Heijer, M D & Broekman, B F P 2023, ' Sex hormones, insomnia, and sleep quality : Subjective sleep in the first year of hormone use in transgender persons ', Sleep Medicine, vol. 107, pp. 316-326 . https://doi.org/10.1016/j.sleep.2023.04.028
Study objectives: Transgender persons can use gender-affirming hormone therapy (GAHT) to align their physical appearance with their identified gender. Many transgender persons report poor sleep, but the effects of GAHT on sleep are unknown. This stud
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c12fcb483a70e99b4dbc20f4f724725
https://research.vumc.nl/en/publications/7764efd3-1a7b-47e0-88df-10d332940145
Zobrazit plný text záznamu
6
Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
Autor: Guy T'Sjoen, Martin den Heijer, Alessandra D. Fisher, Christel J. M. de Blok, Jaap Seidell, Maartje Klaver, Thomas Schreiner, Jos W. R. Twisk, Justine Defreyne, Renée de Mutsert, Daan M. van Velzen, Nota Nienke, Chantal M. Wiepjes
Publikováno v: The Journal of Clinical Endocrinology and Metabolism
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. Oxford University Press
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
The Journal of Clinical Endocrinology & Metabolism, 107(1), E153-E164. ENDOCRINE SOC
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, T'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, t'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Introduction Excess visceral fat increases the risk of type 2 diabetes and cardiovascular disease and is influenced by sex hormones. Our aim was to investigate changes in visceral fat and the ratio of visceral fat to total body fat (VAT/TBF) and thei
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fde1ef24b3f92bb6592bb0080227dbe
https://research.vu.nl/en/publications/f3d8f3f6-00b7-4995-a16e-01ff9d471f70
Zobrazit plný text záznamu
7
Changes in serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy
Autor: Sarah Collet, Noor C Gieles, Chantal M Wiepjes, Annemieke C Heijboer, Tim Reyns, Tom Fiers, Bruno Lapauw, Martin den Heijer, Guy T'Sjoen
Publikováno v: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Journal of clinical endocrinology and metabolism, 108(2), 331-338. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 108(2), 331-338. The Endocrine Society
Collet, S, Gieles, N C, Wiepjes, C M, Heijboer, A C, Reyns, T, Fiers, T, Lapauw, B, den Heijer, M & t'Sjoen, G 2023, ' Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy ', The Journal of clinical endocrinology and metabolism, vol. 108, no. 2, pp. 331-338 . https://doi.org/10.1210/clinem/dgac576, https://doi.org/10.1210/clinem/dgac576
Background Initiating feminizing gender-affirming hormone therapy (GAHT) in transgender women causes a steep decline in serum testosterone. It is unknown if testosterone concentrations change further and whether adrenal androgen levels change during
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc6a16c5f87abf2d6cf360b3519ddf3
https://hdl.handle.net/1854/LU-01GT969WVBMRV6WK0Q1S8RS2TQ
Zobrazit plný text záznamu
8
Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
Autor: Elfi B. Conemans, Alessandra D. Fisher, Suzanne M E Kuijpers, Chantal M. Wiepjes, Guy T'Sjoen, Martin den Heijer
Publikováno v: Journal of Clinical Endocrinology and Metabolism, 106(10), E3936-E3945. The Endocrine Society
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Kuijpers, S M E, Wiepjes, C M, Conemans, E B, Fisher, A D, Tsjoen, G & den Heijer, M 2021, ' Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women : Results from the ENIGI Study ', Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 10, pp. E3936-E3945 . https://doi.org/10.1210/clinem/dgab427
Context Cyproterone acetate (CPA) is a competitive inhibitor of the androgen receptor and exerts negative hypothalamic feedback. It is often used in combination with estrogens in trans women to achieve feminization. However, CPA has been associated w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b05da7717c2dc4e47b2cecc98377cdd5
https://doi.org/10.1210/clinem/dgab427
Zobrazit plný text záznamu
9
Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people
Autor: Linda J. Schoonmade, M. den Heijer, R. A. Meursinge Reynders, R. E. G. Jonkman, M. F. Van den Bosch, Chantal M. Wiepjes
Publikováno v: Systematic Reviews, 10(1):109. BioMed Central
Systematic Reviews, Vol 10, Iss 1, Pp 1-8 (2021)
Van den Bosch, M F, Wiepjes, C M, Den Heijer, M, Schoonmade, L J, Jonkman, R E G & Meursinge Reynders, R A 2021, ' Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people : a protocol for a scoping review ', Systematic Reviews, vol. 10, 109, pp. 1-8 . https://doi.org/10.1186/s13643-021-01668-8
Systematic reviews, 10(1):109. BioMed Central
Systematic Reviews
Systematic Reviews, 10:109, 1-8. BioMed Central
van den Bosch, M F, Wiepjes, C M, den Heijer, M, Schoonmade, L J, Jonkman, R E G & Meursinge Reynders, R A 2021, ' Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people: a protocol for a scoping review ', Systematic Reviews, vol. 10, no. 1, 109 . https://doi.org/10.1186/s13643-021-01668-8
Background Gender-affirming hormone (GAH) therapy aims to support the transition of transgender people to their gender identity. GAHs can induce changes in their secondary sex characteristics such as the development of breasts in transgender females
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c1ccf461c126ca8f4afa63ea43844fe
http://www.scopus.com/inward/record.url?scp=85104375067&partnerID=8YFLogxK
Zobrazit plný text záznamu
10
Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
Autor: Justine Defreyne, Theresa A Stangl, Guy T'Sjoen, Elfi Conemans, Thomas Schreiner, Alessandra D. Fisher, Martin den Heijer, Chantal M Wiepjes
Publikováno v: European Journal of Endocrinology, 184(4), 513-520. BioScientifica Ltd.
Stangl, T A, Wiepjes, C M, Defreyne, J, Conemans, E, Fisher, A D, Schreiner, T, t'Sjoen, G & den Heijer, M 2021, ' Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy? ', European Journal of Endocrinology, vol. 184, no. 4, pp. 513-520 . https://doi.org/10.1530/EJE-20-1064
Context Individuals with gender dysphoria can receive gender-affirming hormone therapy. Different guidelines mention a severe risk of liver injury within the first months after the start of treatment with anabolic androgenic steroids, anti-androgens,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cee2ae7ec859dc186eeeef6d713211b
https://doi.org/10.1530/eje-20-1064
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje